UAB Comprehensive Cancer Center Magazine Fall 2016 - Page 7

Innovative Cancer Initiatives Since its last NCI renewal in 2011, the Cancer Center has substantially enhanced research capabilities and infrastructure in several impactful ways: • Optimized the Alabama Drug Discovery Alliance: The ADDA facilitates drug discovery and development by combining the complementary resources that exist at UAB and Southern Research, a Birmingham-based notfor-profit research organization. There are currently 10 cancer projects in the works for drug development in the ADDA. • Developed a dedicated Phase I Clinical Trials unit and program: The Phase I Unit provides a much-needed facility for first-in-human studies at UAB, in which patients can receive both FDA-approved and experimental drugs in one centralized location. The program has 16 first-in-human phase I trials open, and has four more in the clinical trial review pipeline. • Created the UAB Cancer Center/HudsonAlpha Institute for Biotechnology Consortium: The consortium with this Huntsville-based company provides a platform for building research teams focused on cancer and integrating genomic information into efforts to identify risk, prevent disease and direct personalized therapy; use wide-scale genomic sequencing to discover genes responsible for cancer development and progression; and educate members of the Cancer Center so they can apply genomic information to their research and patient care. • Launched the UAB Health System Cancer Community Network and Patient Care Connect: This network consists of 12 hospitals across Alabama, Florida, Georgia, Mississippi and Tennessee that emphasize collaboration between UAB and community cancer centers on evidence-based guidelines for cancer treatment of patients in local communities. The overall idea is to bring cancer care closer to home while reinforcing UAB’s best practices. The network was used to test an innovative new concept in cancer care using lay navigation across the continuum of care to support better health, better health care and lower costs. # K N O W U A B C C C • U A B . E D U / C A N C E R 5